Table 2. Incidence and subhazard ratio of hepatointestinal complications for patients with and without polycystic kidney disease calculated in a competing risk (death) model.
| Polycystic kidney disease | ||||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | |||||||
| Outcome | Event | PY | Rate# | Event | PY | Rate# | Crude SHR† (95% CI) | Adjusted SHR‡ (95% CI) |
| Acute pancreatitis | 160 | 27972 | 5.72 | 302 | 127285 | 2.37 | 2.37 (1.97, 2.86)*** | 2.36 (1.95, 2.84)*** |
| Cholangitis | 113 | 28176 | 4.01 | 188 | 127621 | 1.47 | 2.27 (1.82, 2.83)*** | 2.41 (1.93, 3.01)*** |
| Peptic ulcer bleeding | 532 | 26700 | 19.9 | 1068 | 125502 | 8.51 | 2.42 (2.18, 2.68)*** | 2.41 (2.17, 2.67)*** |
| Cirrhosis | 154 | 28183 | 5.46 | 501 | 127143 | 3.94 | 1.41 (1.18, 1.69)*** | 1.39 (1.16, 1.66)*** |
PY, person-years; Rate#, incidence rate per 1000 person-years.
Crude SHR†, relative subhazard ratio.
Adjusted SHR‡: Covariables found significantly associated with outcome diseases in the univariable competing risk (death) model were further examined using the multivariable competing risk (death) model.
***p < 0.001.